Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: DNA nanodevices detect an acidic nanolayer on the lysosomal surface.

Nature cell biology·2026
Same author

Receptor-Tethered Cytosolic Modulators Enable Spatial Control of Cell Signaling Specificity.

ACS nano·2026
Same author

Image-driven in situ grading of compost maturity using deep feature clustering and supervised prediction.

Bioresource technology·2026
Same author

DNA-Based FRET Nanoscopy Reveals Rapid CD45 Exclusion from Raft-like Domains upon T-Cell Receptor Signaling.

Journal of the American Chemical Society·2026
Same author

Machine learning assisted-hyperspectral imaging for in-situ evaluation of compost maturity.

Waste management (New York, N.Y.)·2026
Same author

Tyndall-effect-based colorimetric enzyme-linked aptamer assay for instrument-free thrombin detection via enzyme-triggered degradation of MnO<sub>2</sub> nanosheets.

Analytical and bioanalytical chemistry·2026

Related Experiment Video

Updated: Aug 24, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K

Aptamer-Based Cancer Cell Analysis and Treatment.

Limei Wu1, Yutong Zhang1, Zhimin Wang1

  • 1Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan, 410082, P. R. China.

Chemistryopen
|October 20, 2022
PubMed
Summary

Aptamers, or "chemical antibodies," offer precise cancer cell analysis and treatment. These DNA/RNA molecules provide advantages like easy synthesis and high selectivity for advanced cancer theranostics.

Keywords:
aptamerscancer theranosticscell imagingcell recognitiontargeted therapy

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Experiment Videos

Last Updated: Aug 24, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nanotechnology

Background:

  • Aptamers are single-stranded DNA/RNA oligonucleotides with high affinity and selectivity for targets.
  • Known as "chemical antibodies," aptamers offer advantages like easy synthesis, modification, programmability, and biocompatibility.

Purpose of the Study:

  • To review recent advancements in aptamer-based strategies for cancer theranostics.
  • To highlight the application of aptamers in precise cancer cell analysis and treatment.

Main Methods:

  • Literature review of recent studies on aptamer development and application in cancer research.
  • Focus on aptamer-based strategies for cancer diagnosis and therapy.

Main Results:

  • Aptamers demonstrate significant potential as molecular tools in cancer theranostics.
  • Recent progress shows aptamer-based strategies enable precise analysis and targeted treatment of cancer cells.

Conclusions:

  • Aptamers are highly promising for developing novel cancer diagnostic and therapeutic agents.
  • Further research into aptamer applications will advance cancer theranostics.